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Rift Valley fever virus detection 
in susceptible hosts with special 
emphasis in insects
K. M. Gregor1,7, L. M. Michaely1,7, B. Gutjahr2,7, M. Rissmann2, M. Keller2, S. Dornbusch3, 
F. Naccache3, K. Schön3, S. Jansen4, A. Heitmann4, R. König2, B. Brennan5, R. M. Elliott5, 
S. Becker3, M. Eiden2, I. Spitzbarth6, W. Baumgärtner1*, C. Puff1,8, R. Ulrich2,6,8 & 
M. H. Groschup2,8
Rift Valley fever phlebovirus (RVFV, Phenuiviridae) is an emerging arbovirus that can cause 
potentially fatal disease in many host species including ruminants and humans. Thus, tools to 
detect this pathogen within tissue samples from routine diagnostic investigations or for research 
purposes are of major interest. This study compares the immunohistological usefulness of 
several mono- and polyclonal antibodies against RVFV epitopes in tissue samples derived from 
natural hosts of epidemiologic importance (sheep), potentially virus transmitting insect species 
(Culex quinquefasciatus, Aedes aegypti) as well as scientific infection models (mouse, Drosophila 
melanogaster, C6/36 cell pellet). While the nucleoprotein was the epitope most prominently detected 
in mammal and mosquito tissue samples, fruit fly tissues showed expression of glycoproteins 
only. Antibodies against non-structural proteins exhibited single cell reactions in salivary glands 
of mosquitoes and the C6/36 cell pellet. However, as single antibodies exhibited a cross reactivity 
of varying degree in non-infected specimens, a careful interpretation of positive reactions and 
consideration of adequate controls remains of critical importance. The results suggest that primary 
antibodies directed against viral nucleoproteins and glycoproteins can facilitate RVFV detection 
in mammals and insects, respectively, and therefore will allow RVFV detection for diagnostic and 
research purposes.
Rift Valley fever phlebovirus (Phenuiviridae, RVFV) is a zoonotic, emerging and vector-borne disease, which 
was firstly discovered in sheep in the Rift Valley province in Kenya,  Africa1,2. To date it is endemic in  Africa3,4 
and the Arabian  Peninsula5, where outbreaks depend on climatic and ecological conditions, vector behavioral 
 factors3,4,6 and viral genetic  diversity7–9. This arthropod-borne disease affects humans as well as domestic animals, 
including ruminants and camels, which serve as amplifying  hosts10–12.
The majority of human infections leads to febrile disease, while small percentages result in hemorrhagic fever, 
maculo-retinitis, late-onset encephalitis, miscarriage as well as hepatic and renal  failure10,13–15. Ruminants, espe-
cially sheep and goats, suffer from sudden and widespread abortions and high mortality rates in neonates and 
 juveniles16,17. Humans usually acquire infections by contact with infected animal tissues and fluids, but animals 
are usually infected by mosquito  bite12,18–26.
Over 50 mosquito species have tested positive for  RVFV4, including Culex pipiens quinquefasciatus (Cx.
qu.)27–31 and Aedes aegypti (A.ae.)28,29,32 as natural vectors in endemic areas and Aedes albopictus (A.alb.)33,34 
as a potential vector in Europe and the United States. The abundance of competent vectors in  Africa4,23 along 
with wind transfer of  mosquitoes35, wildlife  fluctuation36, irrigation  farming29 and suitable climatic  conditions37 
promote the re-emergence of RVFV in Africa. Furthermore, RVFV poses an imminent threat to non-African 
regions including Europe and North  America23,38–40 as livestock  trading18,25,41,  globalization42 and changing 
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climatic  conditions43,44 promote the emergence of this disease. Another important issue comprises that various 
native mosquitoes on the European continent present as potent vectors of RVFV in several  studies34,45,46. There-
fore, RVFV is of major concern to public health and of economic importance. In addition, it represents a prime 
example of a disease, which is currently approached by one-health  concepts4,47.
Given this background, current investigations focus on molecular pathogenesis during the course of disease 
within mammalian and insect hosts. RVFV is a single-stranded, negative- or ambisense RNA virus and consists 
of three RNA segments (S, M, and L). The L segment encodes the RNA dependent polymerase, responsible for 
virus transcription, while the M segment encodes non-structural proteins (78 kDa NSm, 14 kDa NSm) and 
two glycoproteins (Gc, Gn)48,49. The S segment encodes for the nucleoprotein (N) and a non-structural protein 
(NSs)12,50. The glycoproteins enable the fusion of virions with host cells, while the nucleoprotein encapsidates 
the genome. NSs is regarded to be the main virulence factor and its mechanism of action facilitates the evasion 
of the mammalian innate immune  system50–52. However, NSs might not be required for RVFV maintenance in 
 mosquitoes53,54. While the 14 kDa NSm protein is able to suppress caspase-induced apoptosis in mammalian 
host cells supporting viral  pathogenesis55,56, the 78 kDa Nsm and the 14 kDa Nsm are discussed to be of minor 
importance for virus maturation and replication in  mammals48,55,57. In contrast, the 78 kDa Nsm protein plays 
an important role in  insects58,59.
Beside natural  hosts60–63, laboratory animals such as mice, rats, gerbils, but also monkeys are widely used 
models of experimental RVFV infection in order to assess mechanisms of disease, potential vaccines, or 
 therapeutics51,64,65. In addition, fruit flies serve as model organisms to understand several aspects of disease in 
mammals and insects, including innate immune  pathways66–68 and viral  pathogenesis69,70. Especially the mode 
of neuroinvasion in mammals or the influence on nervous functions in mosquitoes are not fully elucidated in 
RVFV pathogenesis so  far71–75. Therefore, fruit flies enable targeted investigations, since many physiological and 
biochemical mechanisms are highly  conserved76,77.
Veterinary and public health authorities as well as scientific investigations on RVFV require diagnostic tools 
for virus detection. In this context, visualization of viral proteins within tissue samples is essential to identify 
its cell tropism and is commonly assessed by using immunohistochemistry. To facilitate these investigations the 
aim of the present study was to analyze comparatively several mono- as well as polyclonal antibodies directed 
against RVFV.
This study included different species of interest in RVFV research. In accordance with the natural spread, 
sheep and RVFV transmitting mosquitoes such as Cx.qu. and A.ae. were used to assess the diagnostic value of 
RVFV targeting antibodies in immunohistochemistry. Furthermore, mice, fruit flies (Drosophila melanogaster) 
and an insect cell line (C6/36) of A.alb were evaluated as models of infection.
Results
This study analyzed the usability of various monoclonal and polyclonal antibodies directed against RVFV 
(Table 1) using immunohistochemistry on tissues from sheep and RVFV transmitting mosquitoes (C.qu., A.ae.). 
In addition, mice, Drosophila melanogaster strain cinnabar brown (D.mel. cnbw) and strain yellow-white (D.mel. 
yw) as well as an insect cell line (C6/36) of A.alb. were also evaluated as models of infection.
RT-qPCR. Initially, liver tissues of sheep and mice as well as homogenates of fruit flies and mosquitoes were 
investigated using RT-qPCR for verification of RVFV-infection.
Brain homogenates of five infected D.mel. cnbw and yw each revealed Ct values of 27.15–32.89 (D.mel. cnbw) 
and 26.55–31.27 (D.mel. yw). RT-qPCR with formalin-fixed and paraffin-embedded (FFPE) material of RVFV-
infected and mock-infected mosquito (Cx.qu. and A.ae.) as well as fruit fly (D.mel. cnbw and yw) species lacked 
any amplifiable genetic material.
Table 1.  List of antibodies tested to detect RVFV. *: Microwaved in citrate buffer for 20 min at 600 W; DAB: 
3,3′-diaminobenzidine; FLI: Friedrich–Loeffler-Institute, Greifswald; mc: monoclonal; Ns: non-structural, pc: 
polyclonal; USAMRIID: United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, 
Maryland, USA.
Primary antibody Epitope Clonality/host species Dilution Pretreatment Secondary antibody Chromogen Source
Np9 Nucleoprotein mc, mouse 1:200 Citrate buffer* Goat anti-mouse DAB FLI81
polyNp Nucleoprotein pc, rabbit 1: 3000 None Goat anti-rabbit DAB FLI81
S24Np Nucleoprotein pc, sheep 1:8000 (mammals)/1:130.000 (insects) None Rabbit anti-sheep DAB FLI
82
Gc9A9 Glycoprotein Gc mc, mouse 1:200 Citrate buffer* Goat anti-mouse DAB FLI81
polyGc Glycoprotein Gc pc, rabbit 1:3000 None Goat anti-rabbit DAB FLI81
Gn164b Glycoprotein Gn mc, mouse 1:100 Citrate buffer* Goat anti-mouse DAB FLI81
7B6 Glycoprotein Gn mc, mouse 1:50 Citrate buffer* Goat anti-mouse DAB USAMRIID83
polyGn Glycoprotein Gn pc, rabbit 1:3000 None Goat anti-rabbit DAB FLI84
NSs5F12 Ns protein NSs mc, mouse 1:100 Citrate buffer* Goat anti-mouse DAB FLI85
NSm1E9A2 Ns protein NSm mc, mouse 1:50 Citrate buffer* Goat anti-mouse DAB FLI85
3
Vol.:(0123456789)
Scientific Reports |         (2021) 11:9822  | https://doi.org/10.1038/s41598-021-89226-z
www.nature.com/scientificreports/
Liver homogenates of RVFV (strain 35/74) infected sheep revealed Ct values ranging from 25.22 to 27.94 
indicating the presence of viral genome in the organ. Crl:NU(NCr)-Foxn1nu mice infected with the highly virulent 
RVFV strain 35/74 were strongly positive (Ct values ranging from 12.84 to 13.13). C57Bl/6-IFNARtmAgt mice 
infected with RVFV (strain MP12) were positive (Ct values ranging from 16.33 to 19.57). Samples of mock-
infected sheep and from both mock-infected mouse strains were negative for RVFV-specific nucleic acids.
Antigen intensity and dissemination. Immunoreactivity of the different antibodies was characterized 
in RVFV-infected insects and mammals. A detailed overview about the organ involvement is given in Table 2.
C6/36 cell pellet. Nucleoprotein was present as a cytoplasmic, granular signal within moderate numbers (30–
60%) of RVFV-infected C6/36-cells using the antibodies Np9 (Fig. 1), polyNp and S24Np (Table 2). The use of 
the antibody Gc9A9 yielded moderate numbers (30–60%) of RVFV-infected C6/36 cells with the same reaction 
pattern as seen for anti-nucleoprotein antibodies (Fig. 2). All remaining antibodies directed against glycopro-
teins (polyGc, Gn146b, 7B6 and polyGn) labeled low numbers (< 30%) of RVFV-infected C6/36 cells with a 
cytoplasmic, granular reaction. Antigen was present in low numbers of RVFV-infected cells (< 30%) with an 
intracytoplasmic and nuclear, granular reaction using NSs5F12 (Fig. 3), while NSm1E9A2 did not show a reli-
able reaction in virus infected C6/36 cells. Non-infected cells presented a low to moderate background for Np9, 
Gc9A9 and all polyclonal antibodies. In contrast, non-infected controls were free of labeling as well as back-
ground staining using remaining monoclonal antibodies (see Supplementary Fig. S1-S22 online).
Mosquito species. In both RVFV-infected mosquito species, a cytoplasmic immunoreactivity was present in 
various organs using antibodies directed against the nucleoprotein. While signals were strong and well defined 
with Np9 (Fig. 4–5), a more subtle, granular signal was observed using S24Np. Both aforementioned antibodies 
stained single cortical cells from head ganglia as well as the salivary gland falsely positive in mock-infected indi-
viduals. Moreover, a variable low to moderate background staining was present in both antibodies in infected 
and mock-infected specimens. The use of ovine normal serum as an antibody negative control revealed a vari-
able low to high background staining in Cx.qu. and A.ae. Using the antibody polyNp, a distinction between 
a cytoplasmic, granular labeling from the variably intense background was not possible in infected as well as 
mock-infected individuals (Table 2).
Application of antibodies directed against glycoproteins led to a distinct, cytoplasmic, granular labeling of 
varying degree. Gc9A9 (Fig. 6–7) yielded the most intense signal and broadest organ involvement (Table 3) in 
infected mosquitos. A similar signal of decreasing amount was observed using Gn164b and 7B6. Mock-infected 
controls presented a false positive, cytoplasmic, homogenous, partly granular labeling of single cortical cell 
bodies of body ganglia, oenocytes, nephrocytes and salivary gland using Gc9A9. Furthermore, immunostaining 
with Gn164b and 7B6 revealed a false positive staining in oenocytes and/or a single cortical cell of the thoracic 
ganglion in mock-infected A.ae., while they remained negative in mock-infected Cx.qu. In addition, infected 
and mock-infected mosquitos displayed a low to moderate background staining of trophocytes, gastrointestinal 
tract and ovaries with Gc9A9. In contrast, a background reaction was lacking or mild using Gn164b and 7B6.
The polyclonal antibodies polyGc and polyGn showed a variably strong background reaction and a rather 
diffuse cytoplasmic labelling pattern in infected and mock-infected specimens resulting in the impossibility to 
identify a virus specific signal.
A mild, intracytoplasmic and nuclear, granular labeling was present using NSs5F12 in infected mosquitos 
(Fig. 8–9). Mock-infected controls displayed a mild background staining in variable cells such as oenocytes, 
Table 2.  Immunopositive signals in RVFV-infected specimens. A.ae.: Aedes aegypti; Cx.qu.: Culex pipiens 
quinquefasciatus; D.mel. cnbw: Drosophila melanogaster cinnabar brown; D.mel. yw: Drosophila melanogaster 
yellow-white; n.a.: not assessed; n.e.: not evaluable; +: positive reaction in insect tissue, low numbers (< 30%) of 
positive cells in mammals and C6/36 cell pellet; ++: moderate numbers (30–60%) of positive cells in mammals 
and C6/36 cell pellet; +++: high numbers (> 60%) of positive cells in mammals and C6/36 cell pellet; −: no 
reaction; *: false positive labeling in non-infected specimens; #: unspecific background of varying degree.
Antibody
Insects Mammals





Np9 ++# +*,# +*,# +*,# +*,# +++*,# +++# +++#
polyNp ++# n.e. n.e. n.e. n.e. ++# +++# −
S24Np ++# +*,# +*,# n.e. n.e. +++*,# +++ +++
Gc9A9 ++# +*,# +*,# +*,# +*,# ++ +++*,# ++#
polyGc +# n.e. n.e. n.e. n.e. +# ++ +++
Gn164b + +# +*,# −* −* +# ++# ++#
7B6 + +# +*,# +* −* −# − ++*,#
polyGn +# n.e. n.e. n.e. n.e. +# +# +#
NSs5F12 + +*,# +*,# −# −# −# ++# ++*,#
NSm1E9A2 − + + −# −# −# −# ++*,#
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trophocytes and nephrocytes. Labeling with NSm1E9A2 revealed a mild, cytoplasmic, granular reaction in 
RVFV-infected Cx.qu. and A.ae., while mock-infected controls showed no reactivity (see Supplementary Fig. S23-
S66 online).
Fruit flies. Both strains of fruit flies revealed the same staining pattern with most of the antibodies used. A 
cytoplasmic and granular labeling was present in RVFV-infected fruit flies using the antibody Np9 (Fig. 10), 
Table 2). Mock-infected controls presented a false positive, cytoplasmic, granular signal in cortical cell bodies 
of head ganglia and a variable, mild background staining of fat body and gastrointestinal tract. Due to the high 
Figure 1–15.  Comparison of epitope expression in mammal and insect specimens with intracytoplasmic 
(arrowheads) or intranuclear (arrows), granular signals for Rift Valley fever virus (RVFV). Figure 1–3: 
Immunoreactivity in RVFV-infected C6/36 cell pellet for the antibodies Np9 (1), Gc9A9 (2) and NSs5F12 (3). 
Figure 4–9: Immunohistochemical demonstration of the antibodies Np9 (4-5), Gc9A9 (6-7) and NSs5F12 (8-9) 
in RVFV-infected Culex pipiens quinquefasciatus (Fig. 4, 6, 8) and Aedes aegypti (Fig. 5, 7, 9). Figure 10: 
Immunoreactivity in RVFV-infected Drosophila melanogaster yellow-white for the antibody Np9. Figure 11: 
Immunohistochemical demonstration of the antibody Gc9A9 in Drosophila melanogaster cinnabar brown. 
Figure 12–13: Immunoreactivity in RVFV-infected ovine liver tissue for the antibodies Np9 (12) and 
Gc9A9 (13). Figure 14–15: Immunohistochemical demonstration of the antibodies S24Np (14) and Gc9A9 
(15) in RVFV-infected C57Bl/6-IFNARtmAgt murine liver tissue. Note the signal within multifocal lesions in 
ovine liver samples (Fig. 12–13). In contrast, C57Bl/6-IFNARtmAgt mice exhibited a diffuse expression of Rift 
Valley fever antigen (Figure 14–15). am anterior midgut, c cardia, d diverticulum, e esophagus, fm flight muscle, 
sg salivary gland, tg thoracic ganglia, t trophocytes.
Table 3.  Organs with immunopositive signals in RVFV-infected insect specimens. A.ae.: Aedes aegypti; 
Cx.qu.: Culex pipiens quinquefasciatus; D.mel. cnbw: Drosophila melanogaster cinnabar brown; D.mel. yw: 
Drosophila melanogaster yellow-white; n.a.: not assessed; n.e.: not evaluable; +: positive reaction; −: no reaction. 
*false positive labeling in non-infected specimens. #unspecific background of varying degree.
Antibody
Salivary gland Cortical cell bodies of ganglia Foregut/hindgut
Cx.qu. A.ae. D.mel. cnbw D.mel. yw Cx.qu. A.ae. D.mel. cnbw D.mel. yw Cx.qu. A.ae. D.mel. cnbw D.mel. yw
Np9 +* +* n.a. n.a. +* +* +* −* +/+ +/+ −# −#
polyNp n.e. n.e. n.e. n.e. n.e. n.e. n.e. n.e. n.e n.e. n.e. n.e.
S24Np +* +* n.a. n.a. +* +* n.e −# +/− +/+ n.e −#
Gc9A9 +* +* n.a. n.a. +* +* +* +* +/+# +/+# −# −#
polyGc n.e. n.e. n.e. n.e. n.e. n.e. n.e. n.e. n.e n.e. n.e. n.e.
Gn164b + + n.a. n.a. + + − − +/+ +/+ − −#
7B6 + + n.a. n.a. − −* + − +/− +/+ − −#
polyGn n.e. n.e. n.e. n.e. n.e. n.e. n.e. n.e. n.e. n.e. n.e. n.e.
NSs5F12 + + n.a. n.a. + − − − +/− − −# −#
NSm1E9A2 + + n.a. n.a. − − − − − +/− −# −#
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background reaction, a virus-specific signal was not discernable using the antibodies polyNP and S24Np in 
infected and mock-infected individuals. Antibody negative controls treated with ovine normal serum revealed 
a variably strong background staining.
The antibody Gc9A9 presented the strongest and broadest cytoplasmic, granular immunolabeling (Fig. 11, 
Table 3) in RVFV-infected individuals. Using the antibodies Gn164b and 7B6 resulted in a diffuse, cytoplasmic 
immunoreactivity in tropho- and oenocytes, whereby the antibody 7B6 also labeled cytoplasm of cortical cell 
bodies of head ganglia in a granular pattern in D.mel. cnbw. However, immunostaining with Gc9A9 yielded a 
granular, false positive labeling of cortical cell bodies of head ganglia and a variably strong background reac-
tion in various organs including the gastrointestinal tract and the fat body in mock-infected controls. Using the 
antibodies Gn164b and 7B6, mock-infected controls presented a mild, diffuse, cytoplasmic labeling of the fat 
body. As with mosquitoes, using the antibodies polyGn and polyGc, specific immunolabeling was indiscernible 
from a high background reaction.
Regarding non-structural proteins, labeling was diffuse in the cytoplasm of trophocytes and oenocytes in 
RVFV-infected fruit flies using the antibodies NSs5F12 and NSm1E9A2. In mock-infected individuals, a mild 
background reaction was present in fat body and gastrointestinal tract (see Supplementary Fig. S67-S110 online).
Sheep. In RVFV-infected sheep, the antibodies Np9 (Fig. 12) and S24Np showed a strong, cytoplasmic granular 
reaction within > 60% of hepatocytes and Kupffer cells. However, samples from mock-infected controls dis-
played a diffuse false positive reaction within Kupffer cells, while S24Np exhibited diffuse background labeling. 
PolyNp showed the same pattern with a lower intensity (30–60% of hepatocytes and Kupffer cells).
Gc9a9 (Fig. 13) displayed a moderate reactivity (30–60% of hepatocytes and Kupffer cells) within infected 
liver samples. PolyGn, Gn164b and PolyGc showed a mild (< 30% of hepatocytes and Kupffer cells) reaction in 
RVFV-infected samples and a diffuse, non-specific background labeling.
No immunolabeling with 7B6, NSs5F12 or NSm1E9A2 was observed in RVFV-infected sheep (see Supple-
mentary Fig. S111-S132 online).
Mice. Immunolabeling of murine samples with Np9 and S24Np (Fig. 14) antibodies resulted in a granular, cyto-
plasmic signal in > 60% of hepatocytes and Kupffer cells with unspecific background staining by Np9. PolyNp 
exhibited no reactivity within Crl:NU(NCr)-Foxn1nu mice, while in C57Bl/6-IFNARtmAgt mice the result equaled 
the Np9 reaction.
Gc9a9 (Fig. 15) and polyGc labeling was moderate (30–60% of hepatocytes and Kupffer cells) to strong (> 60% 
of hepatocytes and Kupffer cells) with mild unspecific background by Gc9a9 staining in both mouse strains.
Gn164b and polyGn labeling was mild (< 30% of hepatocytes and Kupffer cells) to moderate (30–60% of 
hepatocytes and Kupffer cells) with moderate background staining that was less pronounced in the samples of 
Crl:NU(NCr)-Foxn1nu mice. 7B6 did not show any reaction in C57Bl/6-IFNARtmAgt mice, while it labeled mod-
erate numbers (30–60%) of hepatocytes and Kupffer cells in infected and control samples from Crl:NU(NCr)-
Foxn1nu mice alike.
RVFV-infected murine liver samples displayed a moderate (30–60% of hepatocytes) cytoplasmic, granular 
labeling and moderate unspecific background staining using NSs5F12 while the reactivity of NSm1E9A2 was 
congruent with 7B6. Both antibodies against non-structural proteins exhibited false-positive reactions with 
mock-infected control samples of Crl:NU(NCr)-Foxn1nu mice. (see Supplementary Fig. S133-S176 online).
Discussion
The detection, control and surveillance of RVFV in vertebrate and invertebrate species is of increasing interest 
throughout the past decades as RVF poses a global public health and economic risk  factor23,38–40. This study 
assessed the usefulness of a panel of 10 different antibodies to detect the presence of RVFV in FFPE tissue sec-
tions of mammal and insect specimens. Therefore, sheep as an economically important host, potentially RVFV 
transmitting mosquitoes (Cx.qu., A.ae.) and mice, fruit flies (D.mel. cmnb and yw) and a mosquito cell line (C6/36 
cell line of A.alb.) as scientific models of infection were comparatively analyzed.
The detailed evaluation of obtained signals revealed, that the anti-nucleoprotein antibodies Np9 and S24Np 
yielded a strong immunopositive signal in all investigated specimens, except for S24Np in D.mel. In contrast, 
glycoprotein antibodies presented a reduced signal in RVFV-infected samples, except for Gc9A9 in insect speci-
mens. In fruit flies, it produced the strongest antigen-positive signal. On the other hand, the application of 7B6 
demonstrated no immunoreactivity in ovine tissue and D.mel. yw. The polyclonal antibodies directed against 
Np, Gn and Gc did not serve useful for detection of the RVFV proteins as they lacked any specific reaction. The 
non-structural protein antibodies failed to detect RVFV antigen conclusively in most FFPE tissue samples with 
the exception of mosquito specimens. While viral proteins were detectable by NSs5F12 in both mosquito spe-
cies and C6/36 cells, the antibody NSm1E9A2 only produced a specific signal in A.ae. Noteworthy, even though 
RVFV MP12 strain shows multiple amino acid substitutions, distributed over all three segments, when comparing 
to its parental strain  ZH54878, there was no notable difference in staining intensity among mice infected with 
RVFV 35/74 or RVFV MP12, respectively. Therefore, the known epitopes of monoclonal antibodies Gn164b, 
Gc9A9 (see Supplementary material online) and  7B679, but also the unknown epitopes of Np9, NSs5F12 and 
NSm1E9A2 seem to be rather conserved.
The results in mammals are congruent with previous investigations indicating a prominent expression of the 
S segment in mammals over the M and L  segment80. This is reflected in the reactivity of the applied antibodies. A 
study on antiviral RNAi in insects provides evidence that the M segment of RVFV is highly abundant in insects, 
which might explain the strong signal produced by the Gc9A9 antibody. Furthermore, the present study shows 
that detection of the nonstructural protein 78 kDa NSm was only possible in the salivary gland of mosquitos. 
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Unfortunately, due to its small size fruit fly salivary glands were not present in all slides investigated. Therefore, 
no comparative data were obtained in this study regarding the 78 kDa NSm expression within the salivary gland 
of this species. The non-structural 78 kDa RVFV-NSm protein is important for RVFV infection in insects as 
studies with modified RVFV strains lacking the 78 kDa NSm and 14 kDa NSm proteins resulted in a reduction 
of virus infection, dissemination and transmission potential in A.ae. and to a lesser extent in Cx.qu.81,82.
In comparison to mice and sheep, an antigen-positive signal with the anti-NSs-antibody was detected in mos-
quitoes and C6/36 cells in this study to a higher extent. These findings are in disagreement with previous studies 
that show only low or no expression of NSs in insect cell lines when compared to mammalian  cells52,54. Moreover, 
the cause of the unexpected observation that single cells in RVFV-infected mosquitoes and the infected C6/36 
cell pellet display a nuclear and cytoplasmic immunoreactivity remains unclear and requires further studies. 
However, it is noteworthy that the observed intracellular and -nuclear distribution pattern of NSs might repre-
sent species-specific in vivo conditions of the RVFV infection cycle, especially as in vivo and in vitro observed 
mechanisms cannot simply be extrapolated across species or environmental settings in  nature83,84.
Another observation that demands careful interpretation is the RVFV distribution and signal intensity in 
insect specimens. While RVFV antigens in fruit flies were mainly expressed in fat body and nervous system, 
they were present in almost the entire body in Cx.qu. and A.ae.  mosquitoes85. It should be mentioned that the 
immunohistological demonstration of RVFV proteins was increased in multiple organs in A.ae. mosquitoes, 
notwithstanding that the mosquito specimens exhibited more or less a similar distribution pattern of RVFV. 
Hence, there must be a limiting factor of infection in D.mel. flies and Cx.qu. mosquitoes in comparison to A.ae. 
mosquitoes. Dietrich et al.70 demonstrated similar findings by investigating the abundance of viRNAs, which 
were markedly reduced in Cx.qu. in comparison to A.ae. Here, a lower infection status was discussed. However, 
this needs to be investigated on a molecular level in future studies.
A critical aspect of this study is the marked cross-reactivity between various antibodies and examined speci-
mens, highlighting the importance of a critical analysis of immunoreactivity and application of adequate nega-
tive controls. This cross-reactivity of various virus specific antibodies within host tissue needs to be taken into 
consideration while performing research with RVFV or during routine diagnostics. The regular false positive 
labeling of cortical cells in the head ganglia of mosquitoes and fruit flies is particularly striking. Similar observa-
tions were described for the fat body and nephrocytes in RVFV-infected Culex pipiens86, which in part were also 
observed in the present study and should therefore be considered as unspecific. The same applies for a diffuse 
staining pattern of applied antibodies. Moreover, there was a strong immunoreactivity within the liver of mock-
infected mammals using the antibodies Np9, Gc9A9, polyGc and polyGn. In ovine tissue, there was a severe 
cross reactivity between the above-named antibodies and antigen-presenting cells.
The results provide highly needed, comparable insights of RVFV distribution and antibody usefulness for 
immunohistological investigations. The antibodies used in the present study, in particular anti-nucleoprotein 
and -glycoprotein antibodies are suitable to detect RVFV in tissues of multiple species. While it is recommended 
to use nucleoprotein-targeted antibodies for general diagnostic detection of RVF, glycoprotein-targeted anti-
bodies pose a competent alternative, especially in insect tissue. Nonetheless, different antigens may be targets 
within scientific investigations of RVF pathogenesis. Therefore, the antibodies directed against non-structural 
RVFV proteins represent a promising tool for future studies, especially in mosquitoes. However, when applying 
different antibodies in different species, the possibility of an unspecific or false positive immunostaining should 
be considered and accurate analysis requires inclusion of appropriate controls. Conclusively, the antibodies 
investigated within the study represent a valuable tool for further diagnostic and scientific use in RVFV detec-
tion and research.
Materials and methods
RVFV origin. RVFV strain MP12 used for C6/36 cells, insects, and mice (Richard Elliott and Benjamin 
Brennan, Institute of Infection, Immunity and Inflammation, Centre for Virus Research, University of Glasgow, 
Glasgow, UK) was propagated using Vero-E6-cells (Collection of Cell Lines in Veterinary Medicine (CCLV), 
#CCLV-RIE 929, Friedrich-Loeffler-Institute (FLI), Riems, Germany) on a 96-well plate in Dulbecco’s Modified 
Eagle’s Medium (DMEM, #DMEM-HXA, Capricorn Scientific GmbH, Ebsdorfergrund, Germany) / 5% fetal 
bovine serum (FBS; #FBS-HI-12A FBS, Capricorn Scientific GmbH, Ebsdorfergrund, Germany) at a tempera-
ture of 33 °C in a humidified atmosphere and a  CO2-content of 5%. Supernatant of infected cells was harvested 
after 3 days with cells showing a cytopathic effect (CPE), characterized by cell lysis in 80% of cells. Additionally, 
mice and sheep were infected with the virulent RVFV 35/74 strain provided by the virus stock of the FLI, Riems, 
Germany. The strain was propagated in a cell culture flask of BHK21 cells using Minimum Essential Medium 
(MEM) supplemented with penicillin–streptomycin and 2% FBS (FLI Bio-Bank, FLI, Riems, Germany) at a 
temperature of 37 °C and 5%  CO2. Supernatant was harvested, when cells showed 80% CPE. A  TCID50 assay, 
calculated as described by Spearman and  Kaerber81, was used to determine the virus titer.
Tissue samples. All utilized specimens were part of different, RVF-related animal experiments, which 
were approved and authorized by the responsible animal welfare officers and the local authorities [Landesamt 
für Landwirtschaft, Lebensmittelsicherheit und Fischerei Mecklenburg-Vorpommern (permissions 7221.3-1-
038/17 and 7221.3-1.1-048/17)] and performed in accordance with the German regulations and legal require-
ments.
C6/36 cells were obtained from the FLI (CCLV, #CCLV-RIE_1299, FLI, Riems, Germany) and maintained in 
T75 tissue culture flasks (#83.3911.002, Sarstedt, Germany) with Schneider’s drosophila medium (#P04-90500, 
PAN Biotech, Aidenbach, Germany)/10% FBS (#S181H, Biowest, Riverside, USA)/1% penicillin–streptomy-
cin/1% Gln/1% non-essential amino acids (#P08-32100, Biochrom, Berlin, Germany)/1% sodium pyruvate 
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(#P04-43100, Pan Biotech, Aidenbach, Germany) in an incubator at a temperature of 25 °C. For further analy-
ses, cells were scraped, washed in phosphate buffer saline (PBS) and centrifuged at 300×g for 5 min to form cell 
pellets of uniform size and cellular  density78.
A.ae. (Bayer, Leverkusen, Germany) and Cx.qu. mosquitoes (origin Malaysia, courtesy of Bayer, Leverkusen, 
Germany), reared at the Bernhard Nocht Institute for Tropical Medicine (BNITM) in Hamburg, Germany, 
served as infection models. Specimens were kept in insectaries with a 12 h:12 h light:dark photoperiod, a relative 
humidity of 80% and at a temperature of 26 °C. Emerged mosquitoes received fructose pads (8% D-Fructose, 
#4981.4, Carl Roth GmbH, Karlsruhe, Germany; 0.02% 4-Aminobenzoic acid, #A9878-5G, Sigma Aldrich, 
Seelze, Germany) ad libitum. Females were additionally fed with a blood meal containing concentrated human 
erythrocytes (Blood group 0, Blood bank, University Hospital Hamburg, expired)/50% fetal bovine serum (FBS; 
FBS-Standard, Pan Biotech, Aidenbach, Germany) for egg production. Egg rafts of the species Culex were kept in 
tap water. Egg rafts of the genus Aedes were dried for 14 days and afterwards placed in tap water. Hatched larvae 
were reared with fish food tablets (Astra fish food, Astra Aquaria GmbH, Hameln, Gemany).
Laboratory strains of D.mel. cnbw and yw (Jean-Luc Imler, Institut de Biologie Moléculaire et Cellulaire; 
Université Luis Pasteur, Strasbourg) were bred in the Research Center for Emerging Infections and Zoonoses 
(RIZ, University for Veterinary Medicine, Hannover). Fruit flies were kept in an environment without light at 
25 °C and 65% relative humidity and received Drosophila food (#66-116, NutriFly-Bloomington formulation; 
Genesee Scientific, El Cajon, CA, USA). Prior to further sample preparation, mosquitoes and fruit flies were 
anesthetized with carbon dioxide for further tissue preparation.
Sheep were obtained from FLI sheep flock in Mariensee (Germany), checked for their health status and kept 
at the FLI, Riems, Germany under BSL 3 conditions. They received water ad libitum and were fed with hay pel-
lets and concentrate (CeravisAG, Rendsburg, Germany). For euthanasia, animals were at first sedated with a 
combination of xylazine (CP-Pharma Handelsgesellschaft mbH, Burgdorf, Germany) and ketamine (Serumwerk 
Bernburg AG, Bernburg, Germany) and finally euthanized with embutramide (T61, MSD, Kenilworth, New 
Jersey, USA) according to manufacturer’s instructions. Thereafter, liver samples were obtained during necropsy.
C57Bl/6-IFNARtmAgt mice were bred in and obtained from the FLI mouse stock, while heterozygous 
Crl:NU(NCr)-Foxn1nu mice were commercially obtained from Charles River Laboratories. Both strains, kept 
at the FLI in isolated ventilated cages, received water ad libitum and were fed with standard mouse food (ssniff 
Spezialdiäten GmbH, Soest, Germany). Prior necropsy for obtaining liver specimen, mice were euthanized at 
given criteria by isoflurane anesthesia and subsequent cardiac blood drain.
Animal and C6/36 cell infection. 1.6 ×  107 C6/36 cells were infected with a  TCID50 of 2.3 ×  106/ml of 
RVFV strain MP12 diluted in Schneider’s drosophila medium and incubated for 24 h at 25 °C. 5–7 day old A.ae. 
and Cx.qu. as well as 5–7 day old D.mel. (strain cnbw and yw) were infected by a lateral injection into the thorax 
via glass capillary (Nanoject II Drummond, Drummond Scientific Company, Broomall, PA). While mosquitoes 
received 27.6 nl with a  TCID50 of 1.6 ×  103/ml/specimen, fruit flies were inoculated with 23 nl with a  TCID50 
of 3.3 ×  103/ml/specimen of RVFV strain MP12. Mosquito as well as fruit fly mock-infected controls received 
27.6 nl and 9.2 nl Schneider’s drosophila medium from BHK21 cells, respectively. Thereafter, mosquitoes and 
fruit flies were kept for another 5 days to guaranty establishment of RVFV infection. While mosquitoes were 
maintained at 27 °C ± 5 °C with a relative humidity of 70%, fruitflies were kept at 25 °C with a relative humidity 
of 65%.
Adult sheep received an intramuscular injection of 1 ml virus suspension with a  TCID50 of  105/ml of RVFV 
strain 35/74. C57Bl/6-IFNARtmAgt mice were infected by a subcutaneous injection of 0.1 ml virus suspension with 
a  TCID50 of 1.4 ×  103/animal of RVFV MP12, while heterozygous Crl:NU(NCr)-Foxn1nu mice received the same 
amount of RVFV 35/74. Likewise, negative controls were mock-infected by subcutaneous application of virus-free 
MEM. After infection, sheep were observed for four days and then euthanized to analyze virus distribution in 
an early stage of RVFV infection. Mice were euthanized after developing symptoms of severe disease according 
to an animal welfare score, which resulted in 2–4 days post infection.
Control of infection status. For the verification of the infection status, fruit fly brains (n = 5) were homog-
enized in 500 µl Schneider’s drosophila medium and viral RNA was purified with QIAamp Viral RNA Mini Kit 
(#52904, Qiagen, Hilden, Germany) according to the manufacturer’s instructions. Additionally, one individual 
per mosquito species (n = 1) and four individuals per fruit fly species (n = 4) of RVFV-infected and mock-infected 
FFPE specimens were homogenized, deparaffinized in xylol (#9713.2, Carl Roth GmbH and Co. KG, Karlsruhe, 
Germany) and subsequently purified using RNeasy FFPE Kit (#73504, Qiagen, Hilden, Germany) according 
to the manufacturer’s instructions. RT-qPCR was performed using Qiagen One Step RT-PCR Kit (#210212, 
Qiagen, Hilden, Germany) and the AriaMX real-time PCR system (Agilent Technologies Deutschland GmbH, 
Waldbronn) using 0.6 μM of the following primers and 0.2 µM of probe: RVFV-F (OSM_162, sense, TGA AAA 
TTC CTG AAA CAC ATG G), RVFL-R (OSM_93, antisense, ACT TCC TTG CAT CAT CTG ATG) and RFVL-
probe (OSM_94, CAA TGT AAG GGG CCT GTG TGG ACT TGT G) as previously  published70. Synthetic RNA 
comprising the target region of the RT-qPCR was used as positive control, while a water sample was used as 
negative control.
For evaluation of mice and sheep by RT-qPCR, liver tissue was lysed in cell culture medium using the Qia-
gen TissueLyser II (Qiagen, Hilden, Germany). After centrifugation, RNA was isolated from supernatant with 
the NucleoMag VET Kit (Machery & Nagel, Düren, Germany) in the automated KingFisher Flex Purification 
System (Thermo Scientific, Waltham, USA). Samples were tested once in RT-qPCR according to a previously 
published RVFV  protocol87.
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Histopathology and immunohistochemistry. Four individuals per insect species, (two in sagittal and 
transversal plane each; n = 2 + 2), and two murine and ovine liver samples each (n = 2) of infected and mock-
infected specimens, respectively, served for histological assessment. One C6/36 cell pellet (n = 1) functioned as 
a system positive control in this study. Insect specimens were fixed in 10% neutral buffered formalin for 24 h, 
while mammal tissue samples were fixed in formalin for 21 days. Thereafter, samples were embedded in paraffin 
wax and routinely cut to generate 2–4 µm thick sections used for routine hematoxylin–eosin (HE) staining and 
immunolabeling.
Evaluation of histopathology was performed on HE-stained  sections88, generated by means of an automated 
slide stainer (Leica ST 4040; Leica Biosystems, Germany).
Regarding immunohistochemistry, a panel of various mono- and polyclonal antibodies against different Rift 
Valley fever virus antigens including viral nucleoproteins, glycoproteins and non-structural proteins (detailed 
in Table 1) were evaluated. All antibodies were initially tested using different concentrations and pretreatments 
including proteinase K. The concentration and pretreatment with the highest efficacy were further employed as 
previously  described89.
Samples were demasked in simmering citrate buffer (pH: 6; #3958.1, Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany) for 20 min using a microwave (Privileg 8020, 800 W) or received no pretreatment. In order to prevent 
non-specific binding, samples were incubated with either goat or rabbit serum, diluted 1:5 in phosphate buffered 
saline (pH 7.2). Thereafter, samples were incubated overnight at 4 °C with primary antibodies, diluted in PBS 
with bovine serum albumin (Albumin Fraktion V, #0163.2, Carl Roth GmbH & Co. KG, Karlsruhe, Germany). 
Biotinylated goat-anti-mouse (1:200; #BA-9200, VECTOR, Biozol Diagnostica Vetrieb GmbH, Eching, Ger-
many), goat-anti-rabbit (1:200; #BA-1000, VECTOR, Biozol Diagnostica Vetrieb GmbH, Eching, Germany) and 
rabbit-anti-sheep (1:200; #BA-600, VECTOR, Biozol Diagnostica Vetrieb GmbH, Eching, Germany) antibodies 
served as secondary antibodies, respectively. Visualization was achieved by the use of the avidin–biotin–peroxi-
dase complex (#PK 6100, Vectastain elite ABC kit, Vector Laboratories, Burlingame, USA) with 3,3′-diaminoben-
zidine tetrahydrochloride (DAB, #32750 25GF, Sigma Aldrich Chemie GmbH, Tauffkirchen, Germany) according 
to the manufacturer’s protocol. Final section preparation included counterstaining with Mayer’s hematoxylin 
(#T865.2, Carl Roth GmbH & Co. KG, Karlsruhe, Germany) and mounting with RotiHistokittII (#T160.1, Carl 
Roth GmbH and Co. KG, Karlsruhe, Germany).
Primary antibodies were either replaced with ascites fluid from non-immunized BALB/c mice (1:1000; #BL 
CL8100, Cedarlane, biologo, Kronshagen, Germany), sheep normal serum (1:3000, serum of sheep from the 
Clinic for Swine, Small Ruminants and Forensic Medicine, University of Veterinary Medicine Hannover, Ger-
many) or rabbit normal serum (1:3000; #R4505, Sigma-Aldrich Chemie GmbH, Tauffkirchen, Germany) in 
antibody negative controls. Furthermore, cross-reactivity of primary and secondary antibodies along with the 
ABC Vectorstain kit and DAB was examined in performing the immunohistological experiment as described 
above but omitting one reagent each in separate experimental runs.
Evaluation of results. Tissue sections were evaluated regarding microscopic lesions and immunolabeling 
by three pathologists using light microscopy (OLYMPUS BX53; Olympus Europa SE & Co. KG, Hamburg, Ger-
many). Immunoreactivity of positive cell immunolabeling was semiquantitatively estimated in mice, sheep and 
the C6/36 cell pellet: mild for < 30% (+), moderate for 30–60% (++) and marked for > 60% (+++) labeled cells 
per high power field. The distribution and morphology of immunolabeling in insects in vivo, was classified as 
either positive (+) or negative (−) with respect to different organ involvement.
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